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protease–helicase
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Background: Hepatitis C virus (HCV) currently infects approximately 3% of the
world’s population. HCV RNA is translated into a polyprotein that during
maturation is cleaved into functional components. One component,
nonstructural protein 3 (NS3), is a 631-residue bifunctional enzyme with
protease and helicase activities. The NS3 serine protease processes the HCV
polyprotein by both cis and trans mechanisms. The structural aspects of cis
processing, the autoproteolysis step whereby the protease releases itself from
the polyprotein, have not been characterized. The structural basis for inclusion
of protease and helicase activities in a single polypeptide is also unknown.
Results: We report here the 2.5 Å resolution structure of an engineered
molecule containing the complete NS3 sequence and the protease activation
domain of nonstructural protein 4A (NS4A) in a single polypeptide chain (single
chain or scNS3–NS4A). In the molecule, the helicase and protease domains
are segregated and connected by a single strand. The helicase nucleoside
triphosphate and RNA interaction sites are exposed to solvent. The protease
active site of scNS3–NS4A is occupied by the NS3 C terminus, which is part
of the helicase domain. Thus, the intramolecular complex shows one product of
NS3-mediated cleavage at the NS3–NS4A junction of the HCV polyprotein
bound at the protease active site.
Conclusions: The scNS3–NS4A structure provides the first atomic view of
polyprotein cis processing. Both local and global structural rearrangements follow
the cis cleavage reaction, and large segments of the polyprotein can be folded
prior to proteolytic processing. That the product complex of the cis cleavage
reaction exists in a stable molecular conformation suggests autoinhibition and
substrate-induced activation mechanisms for regulation of NS3 protease activity.
Introduction
Hepatitis C virus (HCV), a (+)-strand RNA virus of the
Flaviviridae family, is the major etiological agent of post-
transfusion non-A, non-B hepatitis [1]. In infected cells,
the HCV RNA is directly translated into a continuous
3011-residue polypeptide chain [2–4]. The polyprotein is
subsequently cleaved to yield envelope and core proteins,
which assemble into new virus particles, and enzymes
essential for viral replication [5–7]. At least ten proteins
are encoded by the HCV genome and significant progress
has been made in dissecting their biological functions in
the viral life-cycle (for recent reviews, see [8–10]).
Both host cell and virally encoded proteases are required
for maturation of the HCV polyprotein. Initial cleavages
catalyzed by host proteases liberate individual envelope
and capsid proteins, located at the polyprotein N termi-
nus, and the portion of the HCV polyprotein that contains
the viral enzymes, or nonstructural (NS) proteins. This
polyprotein segment contains the free N terminus of non-
structural protein 2 (NS2) — an integral membrane
protein with proteolytic activity [11,12]. NS2, either alone
or in conjunction with NS3 [13,14], then cleaves the
NS2–NS3 scissile bond in what is termed cis processing,
because cleavage involves an intramolecular autoproteo-
lysis step. The NS2-mediated autoproteolysis generates
the NS3 N terminus, and releases a 1984-residue polypro-
tein that incorporates a bifunctional 631-residue enzyme
(NS3) possessing both serine protease and RNA helicase
activities. The NS3 protease is responsible for processing
the remaining polyprotein [7,15–19].
Completion of polyprotein maturation is initiated by auto-
catalytic cleavage at the NS3–NS4A junction. The reac-
tion is catalyzed by the NS3 serine protease and occurs as
a cis processing step. Subsequent NS3-mediated cleavages
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of the HCV polyprotein are thought to involve the recog-
nition of polyprotein cleavage junctions by an NS3 mol-
ecule of another polypeptide and are termed trans
processing events. In these reactions, NS3 liberates an
NS3 cofactor (NS4A), two proteins of unassigned function
(NS4B and NS5A), and an RNA-dependent RNA poly-
merase (NS5B) [20]. 
Many questions concerning the structural events that
occur during polyprotein processing are unanswered. The
cis cleavage reaction by which NS3 releases itself from the
HCV polyprotein requires the polyprotein segment con-
taining the NS3–NS4A junction to bind at the NS3 pro-
tease active site. The C terminus of the NS3 helicase
domain and the N terminus of NS4A reside on either side
of the scissile bond. Previously, only structures of the iso-
lated helicase domain [21] and the protease domain (both
free and in complex with a peptide containing the region
of NS4A known to activate the NS3 protease [22–24])
were available. Modeling of the cis cleavage reaction was
complicated because the relative orientations of the pro-
tease and helicase in the native bifunctional NS3 mol-
ecule were unknown. In addition, structures of the
helicase domain showed a well-defined helix at the C ter-
minus, which implied that either some degree of helix
unfolding occurs on formation of a substrate-recognition
complex typical of chymotrypsin-like serine proteases, or
that the HCV NS3 protease forms a novel substrate-recog-
nition complex. Clearly structural studies of full-length
NS3 are needed to reveal structural aspects of the cis and
trans cleavage reactions.
Studies of this molecule were also undertaken to extend
the structural biology of HCV proteins towards the com-
pleteness achieved for human immunodeficiency virus
(HIV) proteins [25,26]. The NS3–NS4A complex contains
685 residues, comprising nearly 23% of the HCV genome
and 35% of the nonstructural region. A molecular view of
single-chain (sc) NS3–NS4A would aid understanding of
the structural basis for the observed enhancement of heli-
case activity in NS3 relative to the isolated helicase
domain. In addition, several engineered forms of the
NS3–NS4A complex, which are expressed at high levels
and are more soluble and stable in vitro than the native
enzyme, have been reported [27–29]. While the engi-
neered molecules exhibit protease and helicase activities
similar to those of the native complex, crystallographic
analyses were undertaken to validate their use in struc-
ture-based design of protease and helicase inhibitors.
Results
Overall structure
The structure of scNS3–NS4A was solved by molecular
replacement using the protease [22,24] and helicase [21]
domain structures as probe molecules. The structure was
refined to 2.5 Å resolution with a final R factor of 20%
(Rfree 26%). The cross-validated coordinate error is esti-
mated to be 0.22 Å. Data collection and refinement statis-
tics are given in Table 1. In the electron-density maps,
the entire 647-residue polypeptide of both molecules in
the crystallographic asymmetric unit was well-defined
with few exceptions. The molecules were refined without
symmetry constraints and superimpose with a Cα coordi-
nate root mean square deviation (rmsd) of 0.6 Å. A Cα
trace of scNS3–NS4A is shown in Figure 1. The molecule
is globular in shape with approximate dimensions of
65 Å × 65 Å × 75 Å. 
scNS3–NS4A is composed of six subdomains which occur
in sequence along the polypeptide chain (Figure 2). The
protease domain exhibits the dual β-barrel fold that is
common among members of the chymotrypsin serine pro-
tease family. The helicase domain contains two structurally
related β-α-β subdomains and a third subdomain of seven
helices and three short β strands. The latter domain is
usually referred to as the helicase α-helical subdomain.
The 13-residue protease activation domain of NS4A con-
tributes one strand to the N-terminal protease β barrel and
is considered to be the sixth subdomain. The scNS3–NS4A
molecule is colored by subdomain in the schematic repre-
sentation in Figure 2a and the amino acid sequence is
given in Figure 2c.
Differences in subdomain structure in the scNS3–NS4A
molecule and in the structures of the isolated protease
and helicase domains were assessed in several ways.
Inspection of the molecule revealed that the subdomain
folds are similar. Overall preservation of structure is also
apparent when the subdomains from the various struc-
tures are superposed. As detailed in Table 2, the sub-
domains exhibit rmsd values in Cα positions averaging
~0.5 Å. Only the NS3 C terminus dramatically changes
fold in the two structures, and this change results in
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Table 1
Data collection and refinement statistics.
Data collection
Resolution range (Å) 40.0–2.5
Rsym* 0.073
Unique reflections (F ≥ 0) 50,087
Theoretically possible reflections (%) 99.7
Refinement
R factor† 0.20
Rfree (1003 reflections) 0.26
Rms deviation from ideal bond distances (Å) 0.013
Rms deviation from ideal angle (°) 1.67
Protein nonhydrogen atoms 9614
Zinc ions 2
Phosphate ions 2
Ordered water molecules 262
*Rsym calculated for 601,477 reflections where F > 0. †R factor
calculated using 48,937 reflections for which F > 0.
slightly higher deviations on superposition of the helicase
α-helical subdomains. Comparison of the relative B values
(Figure 3) also shows a similar distribution of structural
flexibility for scNS3–NS4A and the isolated domains.
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Figure 1
Stereoview of scNS3–NS4A represented as
a Cα trace. The two crystallographically
independent molecules are shown
superposed and are represented by thin and
thick lines, respectively. Every twentieth
residue is labeled.
Structure
Figure 2
The structure of scNS3–NS4A. (a) Ribbon
diagram of scNS3–NS4A, an engineered
molecule that consists of 631 NS3 residues,
14 NS4A residues known to activate the NS3
protease, and three linker residues. In
scNS3–NS4A the NS4A sequence is linked
to the NS3 N terminus. In the hepatitis C
virus, NS3 and 54-residue NS4A exist as a
tightly associated noncovalent complex.
scNS3–NS4A has six subdomains: two
β barrels in the protease domain (magenta
and red); two β-α-β subdomains (green and
yellow) and one α-helical subdomain in the
helicase (blue) and the NS4A-derived
sequence (cyan). Residues of the protease
catalytic triad (His57, Asp99 and Ser139) are
shown in ball-and-stick representation, and
the protease structural zinc ion is shown as a
white sphere. The red spheres represent a
phosphate molecule located at the NTP-
binding site of the helicase. This view clearly
shows the interaction between the C terminus
(blue) and protease active-site region. (b) The
electrostatic surface potential of NS3 viewed
in the same molecular orientation as (a).
Residues contributing to the region of excess
positive charge (dark blue surface) near the
center of the protease are labeled. Regions of
excess negative charge (red surface) are a
recurrent and poorly understood feature of
helicase structure. (c) The  amino acid
sequences of NS3 and NS4A in one-letter
code, colored by subdomain as in (a).
Junctions in the HCV polyprotein that are
processed by NS3 are aligned below with the
NS3–NS4A autoprocessing site. Yellow bars
denote the conserved P1 and P6 residues.
APITAYSQQTRGLLGCIITSLTGRDKNQVDGEVQVLSTATQSFLATCVNGVCWT
VYHGAGSKTLAGPKGPITQMYTNVDQDLVGWQAPPGARSMTPCTCGSSDLYLVT
RHADVIPVRRRGDSRGSLLSPRPVSYLKGSSGGPLLCPSGHAVGIFRAAVCTRG
VAKAVDFVPVESMETTMRSPVFTDNSSPPAVPQTFQVAHLHAPTGSGKSTKVPA
AYAAQGYKVRVLNPSVAATLGFGAYMSKAHGIDPNIRTGVRTITTGAPVTYSTY
GKFLADGGCSGGAYDIIICDECHSTDSTTILGIGTVLDQAETAGARLVVLATAT
PPGSITVPHPNIEEVALSNTGEIPFYGKAIPIEAIRGGRHLIFCHSKKKCDELA
AKLTGLGLNASGYYRGLDVSVIPTIGDVVVVATDALMTGFTGDFDSVIDCNTCV
TQTVDFSLDPTFTIETTTVPQDAVSRSQRRGRTGRGRRGIYRFVTPGERPSGMF
DSSVLCECYDAGCAWYELTPAETSVRLRAYLNTPGLPVCQDHLEFWESVFTGLT
HIDAHFLSQTKQAGDNFPYLVAYQATVCARAQAPPPSWDQMWKCLIRLKPTLHG
PTPLLYRLGAVQNEITLTHPITKFVMACMSADLEVVTSTWVLVGGVLAALAAYC
LTTGSVVIVGRIILSGRPAVVPDREVLYREFDEMEECASHLPYIEQGMQLAE
LKRLHQINEDCSTPCSGSWLRDIWDWICTV
WSTVSGEAGDDIVCCSMSYTWTGALITPCA
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However, the B value comparison does reveal that several
loops in the helicase and the NS3 C terminus are more
ordered in scNS3–NS4A.
The protease and helicase catalytic centers are segregated
in the bifunctional enzyme (Figure 2a). The nucleoside
triphosphate (NTP) and the single-stranded RNA-
binding sites, as well as the deep surface grooves that
define the helicase active-site region, are oriented away
from the interdomain interface and are exposed to
solvent. In contrast, the NS3 protease active site is ori-
ented towards the molecular interior. The P-side (as
defined by Schechter and Berger [30]) of the substrate-
recognition site and the active-site region are occupied by
the molecule’s own C terminus. The NS3 C terminus is
the P-side product of the cis cleavage reaction at the
NS3–NS4A junction and, following proteolysis, it carries
the C-terminal carboxylate. This is in contrast to the
P′-side (or primed side) segment of the substrate, which
following cis processing at the NS3–NS4A junction con-
tains the N-terminal amino group of NS4A. With the
P-side product bound at the protease active site, the
scNS3–NS4A structure provides the first molecular view
of autoproteolytic polyprotein processing.
Interactions between the protease and helicase domains
The protease and helicase domains are covalently con-
nected by a short solvent-exposed strand incorporating
polypeptide residues Pro182, Val183, Phe184, Thr185 and
Asp186. The connecting strand appears flexible and adopts
a slightly different conformation in each independent copy
of the scNS3–NS4A molecule that comprises the crystallo-
graphic asymmetric unit (Figure 1). The principal surface
interaction between the domains buries ~900 Å2 at the
domain interface and involves residues Tyr56, Gly60,
Ser61, Val78 and Asp79 from the protease domain and
Gly327, Val329, Pro482, Ser483, Gly484, Met485, Pro520,
Gly521 and Val524 from the helicase domain. 
Extensive interactions between the protease and helicase
domains occur around the protease active site. Electron
density for this region of the molecule (Figure 4a) is clear
and allows the precise definition of the intramolecular
interactions. The NS3 C-terminal sequence comprising
residues 626–631 forms an extended antiparallel β strand
along the edge of the protease β barrel, as well as numer-
ous additional interactions between the C-terminal car-
boxylate and protease catalytic residues. The latter
include hydrogen-bond interactions with the His57 imida-
zole and Ser139 hydroxyl of the catalytic triad, and with
the backbone amides of residues 137 and 139 that stabilize
the oxyanion transition state. The six C-terminal residues
of NS3 form 12 hydrogen bonds and create an ~500 Å2
contact surface near the NS3 protease active site.
Details of the intramolecular backbone and sidechain
interactions are shown in Figure 4b. The interaction pat-
terns along the C-terminal strand and with the terminal
carboxylate are similar to those observed in other pro-
tease–product peptide complexes. These include the glu-
tamic-acid-specific protease complex with a tetrapeptide
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Table 2
Comparison of subdomain structure.
Domain Protease Helicase NS4A
Subdomain 1 2 3 4 5 6
Rmsd (Å) 0.5 0.5 0.5 0.5 0.6 0.3
Number of Cα atoms 89 80 141 130 139 11
Subdomains of scNS3–NS4A were superimposed on those of the
isolated protease–NS4A [22] and helicase [21] structures.
Figure 3
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Comparison of mainchain B values. The blue line shows values for
scNS3–NS4A, and the magenta line shows values reported for the
isolated protease [22] and helicase [21] domains. The bar on the
horizontal axis represents the linear sequence and is color coded as in
Figures 2a and 2c. Arrows indicate the N and C termini of the isolated
domain structures. In scNS3–NS4A, the NS4A sequence (cyan) is at
the N terminus of the molecule. In the HCV polyprotein, the NS4A
sequence follows NS3; after processing NS4A is noncovalently
associated with NS3.
ligand [31] (PDB code 1HPG) and the Sindbis virus pro-
tease–peptide complex [32] (PDB code 2SNV). Clearly,
the NS3 C terminus binds in what is evidently a product
complex of NS3-mediated cis cleavage at the NS3–NS4A
junction of the HCV polyprotein.
It is notable that when the proteolysis of peptides corre-
sponding to the polyprotein processing sites is studied
in vitro, inhibition by the P-side products is observed. For
example, while Km values of 10 µM and 3.8 µM are
observed for the 12-residue peptide substrates corre-
sponding to the NS4A–NS4B and NS5A–NS5B junctions,
the P-side hexameric products exhibit Ki values of 0.6 µM
and 1.4 µM, respectively [33]. These observations are con-
sistent with the present structural results that show the
P-side product of cis cleavage at the NS3–NS4A junction
bound in the protease active site. 
Engineered scNS3–NS4A
The NS3 protease is activated by the 54-residue NS4A
protein. Crystallographic studies of the protease domain
have shown that prior to binding NS4A, the NS3 protease
is partially unfolded [23,34]. Protease activation involves
completion of the N-terminal protease β barrel by NS4A,
the ordering of ~30 N-terminal NS3 residues, and assem-
bly of the NS3 serine protease catalytic triad. Only the
central portion of NS4A is required for protease activation.
The functional role of the NS4A C terminus is unknown,
but the hydrophobic N terminus is known to localize the
NS3–NS4A complex at the host cell membrane. 
Using the crystal structure of the NS3 protease domain  in
complex with the NS4A-derived activation peptide, several
groups constructed molecules incorporating both proteins
into a single polypeptide chain [27–29]. In general, the
single chain NS3–NS4A molecules exhibit activities compa-
rable to the native NS3–NS4A complex. Preservation of
activity in the single-chain molecules is consistent with
comparison of the scNS3–NS4A structure to that of the NS3
protease domain in complex with an NS4A-derived peptide.
Superpositions (Figure 5; Table 2) and B value comparisons
(Figure 3) revealed no significant differences in the protease
or NS4A-activation peptide structures. These results are
similar to those observed for other two-chain proteases such
as HIV-1 protease [35,36], pepsinogen [37] and coagulation
factor VIIIa [38], where protein engineering methods
proved effective for the production of soluble, stable pro-
teases for mechanistic and biophysical studies.
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Figure 4
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Structure
Interactions of the NS3 C terminus at the NS3 protease active site.
(a) Stereoview |2Fo–Fc| electron density contoured at 1σ for residues
626–631, and His57 and Ser139 of the catalytic triad. (b) Schematic
diagram of the intramolecular backbone and sidechain interactions.
Hydrogen bonds are shown as dashed lines and distances are given
in Å. The distance between the salt-linked atoms of Lys165 and
Asp626 is 3.6 Å.
Discussion
The C terminus of scNS3–NS4A is the P-side product of
the NS3-mediated cis cleavage at the NS3–NS4A junction
of the HCV polyprotein. In the structure, the P-side product
is bound at the protease active site. Thus, the crystallo-
graphic study reported here provides the first molecular
snapshot of polyprotein processing by autolysis. This
unique structural result advances our understanding of
HCV maturation and viral polyprotein processing in general. 
Several features of the NS3 molecular mechanism can be
extended from this work. First, it is apparent that during
the cis and trans cleavage reactions, both local and global
conformational changes occur in the NS3 structure.
Second, the completeness of the structure allows construc-
tion of a model of NS3 in complex with the NS3–NS4A
junction prior to the cis cleavage reaction. The structure
and model suggest that the individual proteins can be sub-
stantially folded in the polyprotein. Finally, the results
afford a structural basis for the observed enhancement of
helicase activity in the bifunctional enzyme relative to the
isolated domain.
The cis cleavage reaction
The structure of the polyprotein substrate complex prior
to cis cleavage at the NS3–NS4A junction can be readily
modeled from the product complex structure reported
here. This requires the addition of residues 1–20 of NS4A.
In the substrate complex, these residues are situated
between the C terminus of NS3 bound at the protease
active site and residue 21 of the NS4A segment that com-
pletes the protease β barrel. A 20-residue sequence can
easily span the ~20 Å distance between crystallographi-
cally defined residues, and many favorable backbone con-
formations can be modeled. In fact, the distance is
sufficiently short that a small α-helical segment can be
accommodated. Thus the model suggests that a number of
hydrophobic residues, potentially able to form a helical
membrane anchor, can adopt a defined helical secondary
structure prior to proteolytic processing at the NS3–NS4A
junction (Figure 6a).
The trans cleavage reaction
The binding and catalytic cleavage of successive poly-
protein recognition sequences requires the displacement
of the product NS3 C terminus from the protease active
site. In the structure of the isolated helicase domain
[21,39,40], the C terminus forms an α helix ending at
residue 627 followed by an extended tetrapeptide
sequence. In the structure of bifunctional NS3 reported
here, the helix is shorter (Figure 6c) and the C terminus is
more extended in order to form the extensive β-sheet
interactions seen in the product complex and presumably
required for formation of the substrate complex. 
On the basis of the scNS3–NS4A structure, exposure of
the NS3 protease site to polyprotein substrates involves at
least two types of conformational change. First, when the
C terminus of NS3 adopts the conformation observed in
the structures of the isolated helicase domain, the protease
active site becomes more exposed. However, this local
change leaves the substrate-recognition subsites partially
blocked by the helicase. Additional global conformational
changes appear necessary to accommodate a polyprotein
substrate. More complete exposure of the substrate-recog-
nition subsites is achieved by relative rotations of the pro-
tease and helicase domains (Figure 6b). Rigid-body
rotations are readily accomplished by minor changes in
backbone torsional angles within the interdomain strand.
The protease activities towards polypeptide substrates are
similar for the native NS3–NS4A and scNS3–NS4A
enzymes, and for the isolated protease domain [19,41]. This
suggests that relatively little energy is required to disrupt
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Figure 5
Preservation of the NS3 protease domain
and NS4A activation sequence structures
in engineered scNS3–NS4A. Stereoview
superposition of the protease portion of
scNS3–NS4A (blue) on the NS3 protease
domain–NS4A-derived peptide complex
(yellow, PDB code 1A1R [37]). Residues
of NS4A, the linker Ser-Gly-Ser sequence,
and NS3 Ile3 are shown in ball-and-stick
representation.
the cis product complex, possibly because the NS3 C termi-
nus can readily adopt the alternative low-energy α-helical
conformation seen in the isolated helicase structure. Some
structural alterations in the protease domain may occur
during this process and account for differences in P1 speci-
ficity for the cis and trans cleavage reactions (Figure 2c).
The polyprotein substrate itself may promote the struc-
tural changes required for the trans cleavage reaction. All
cleavage sites in the HCV polyprotein contain a conserved
acidic residue at P6 and several contain additional acidic
residues (Figure 2c). In the product complex, the P6
acidic sidechain of Asp626 forms a weak, solvent-exposed
salt linkage with the amino group of Lys165. Although it is
unclear whether this interaction is energetically important,
it is possible that the conserved P6 acidic group serves
another more generalized function. For example, the
acidic P6 residue may interact with the positively charged
region near the protease active site to electrostatically
guide protease–substrate complex formation (Figure 7).
Several basic residues, Arg109, Arg119, Lys136, Arg161
and Lys165, are conserved in this region (Figure 2b).
Similar electrostatic recognition has been observed for the
substrates of proteases such as thrombin [42]. 
Polyprotein processing
The scNS3–NS4A structure suggests a plausible mecha-
nism for polyprotein processing and membrane localization
of HCV enzymes. This process is outlined in Figure 8.
Figure 8a shows the 1984-residue nonstructural polyprotein
anchored to the host cell membrane through a C-terminal
helix. Figure 8b shows a self-associated state of the polypro-
tein where the NS4A-activating sequence has complexed
with the protease domain and the NS3–NS4A cleavage
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Figure 6
Structural changes in NS3 during cis and
trans processing events. Models of (a) the
NS3–NS4A complex prior to cis cleavage and
(b) the NS3 conformation capable of
accommodating HCV polyprotein processing
sites in trans. Color coding corresponds to
that in Figure 2. (c) Stereoview superposition
of the NS3 C terminus (green) and the
isolated helicase domain (blue). Sidechains
with markedly different locations in the two
structures have the same color (Asp626, red;
Leu627, yellow; Glu628, cyan; and Val629,
pink). Val630 and Thr631 are well-defined
only in the scNS3–NS4A crystal structure,
and for completeness are modeled here.
Structural changes in the backbone
conformation are accommodated by
preservation of an important
sidechain–sidechain contact involving a
relatively nondirectional interaction between
the Leu627 sidechain and an aromatic cluster
containing Phe438, Phe531 and His528. 
sequence has bound to the protease active site. Crystallo-
graphic studies of the protease domain have shown that
prior to binding the activating cofactor NS4A, the NS3 pro-
tease is partially unfolded [23,34]. Protease activation
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Structure
Activation of NS3–NS4A. (a) Schematic of the NS3–NS4A complex
following cis cleavage at the NS3–NS4A junction, and a segment of
the nonstructural region of the HCV polyprotein. Both fragments are
attached to the host cell membrane via hydrophobic helices.
Characters 3, 4A, 4B, 5A and 5B denote the nonstructural proteins
NS3, NS4A, NS4B, NS5A and NS5B, respectively. The N and
C termini are labeled. Small red and blue spheres indicate negatively
charged residues on the polyprotein substrate, and positively charged
residues on the NS3 protease domain, respectively. A black triangle
indicates the NS3 protease active site. (b) Electrostatic recognition
between NS3–NS4A and the polyprotein substrate, indicated by a
dashed line. (c) Cleavage at the NS5A–NS5B junction. Local and
global structural changes in NS3 to accommodate the polyprotein
substrate are depicted in (b) and (c). 
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(a) (b) (c) (d)
HCV polyprotein processing in the nonstructural region. Nonstructural
proteins NS3, NS4A, NS4B, NS5A and NS5B are colored purple, red,
green, pink and orange, respectively. (a) Attachment of the 1984-residue
polyprotein to the membrane. (b) NS4A activation and folding of the
NS3 N terminus. (c) Subsequent cleavage reactions. To highlight the
fact that the sequence of cleavage reactions has not been firmly
established, the N terminus of the polyprotein substrate is dotted and the
schematic diagrams are enclosed in a box. (d) The release of NS4B and
NS5A and formation of the replication complex core.
involves completion of the protease β barrel by NS4A and
ordering of the protease domain N terminus.
Information about the sequential order of polyprotein pro-
cessing events within the HCV polyprotein encompassing
NS3 through NS5B suggests that cis cleavage at the
NS3–NS4A junction occurs very rapidly [20]. Interest-
ingly, the NS5A and NS5B proteins appeared before
NS4B and indicate that subsequent cleavages may not be
sequentially ordered along the polyprotein; the latter pro-
cessing events occur in trans (Figure 8c). Modeling studies
suggest that cis cleavage at the NS4A–NS4B junction can
be accommodated even if NS4A serves both as the NS3
activator and carries the NS4A–NS4B junction (Figure 8c).
Polyprotein processing finally results in the liberation of
NS4B, NS5A and NS5B; NS5B along with NS3 consti-
tutes the core of the HCV membrane-associated replica-
tion complex, (Figure 8d) [43]. In the replication complex,
when the proteolytic role of NS3 is presumably complete,
the NS3 structure could revert to the conformation
observed in the crystal structure, where a compact globular
shape is stabilized by interactions between the C terminus
and the protease active-site region.
Bifunctional protease–helicase
HCV is a member of the Flavivirus family, all members of
which possess an NS3 analog with dual protease–helicase
functions [44]. Many studies have demonstrated that the
catalytic efficiency of the protease measured using in vitro
model systems is similar in the isolated domains and the
full-length NS3 bifunctional enzyme [19,41]. In contrast,
helicase activity is enhanced in the full-length NS3 enzyme
relative to the isolated helicase domain [29,41]. Although
the overall helicase fold is preserved in the two structures,
both β-α-β domains are more completely folded in the
bifunctional enzyme (Figure 3). The electron density is
clear for the entire scNS3–NS4A molecule, whereas in
several helicase domain structures residues at the N termi-
nus are disordered [21,39,40]. Stabilization of the helicase
fold in the full-length enzyme may contribute to more
effective utilization of the energy arising from NTP hydrol-
ysis. Additionally, it is known that the NS3 protease
domain contributes binding sites for the helicase RNA sub-
strate [41,45,46]. As shown in Figure 2b, several positively
charged regions suitable for electrostatic binding of RNA
feature prominently on the protease domain surface.
In the native bifunctional enzyme, the protease domain
apparently acts as a localization factor to spatially direct
helicase activity. Association of NS3–NS4A with the host
membrane colocalizes the protease and helicase at the
membrane surface as part of a larger replication complex
with the HCV RNA-dependent RNA polymerase [43]
(Figure 8d). A similar localization mechanism for helicase
regulation is employed by the spliceosome, where at least
seven discrete RNA unwinding activities are involved in
intron processing [47]. The conserved helicase domains
reside within larger, multidomain splicing factors which
form specific intermolecular interactions to appropriately
localize the various helicases.
Biological implications
Hepatitis C virus (HCV) is the major etiological agent of
post-transfusion non-A, non-B hepatitis. Chronic HCV
infections cause liver cirrhosis and, in a significant
number of cases, progress to hepatocellular carcinoma
[48]. HCV currently infects approximately 3% of the
world’s population and has been termed the silent epi-
demic because of its widespread incidence and the long,
10–15 year, latency period between the initial detection of
virus in patients and the onset of clinical symptoms [49].
In infected cells, the HCV RNA is translated into a con-
tinuous polypeptide chain that is subsequently cleaved to
produce envelope proteins, core proteins and nonstruc-
tural (NS) proteins. A more complete understanding of
viral polyprotein processing may aid the discovery of new
therapeutic agents to control or eliminate HCV infections.
We report here the crystal structure of the HCV nonstruc-
tural protein 3 (NS3) — a bifunctional  protease–helicase.
The structure reveals a compact globular molecule stabi-
lized by interactions between the C terminus and the
protease active-site region. Given that HCV polyprotein
processing involves NS3-mediated autoproteolysis at the
NS3 C terminus, this structure represents the complex
between the protease and P-side product of the cis cleav-
age reaction, and thus provides the first structural view of
cis polyprotein processing. The structure, along with previ-
ously determined structures of the isolated protease and
helicase domains, indicates the extent to which local and
global structural rearrangements are required for subse-
quent NS3-mediated polyprotein processing.
Materials and methods
Protein expression and purification
A recombinant single-chain construct in which the NS3-activating
sequence of NS4A (residues 21–32) precedes the N terminus of NS3
(residues 3–631) was cloned and expressed in Escherichia coli as
previously described [28,29]. Throughout the paper, this molecule is
referred to as scNS3–NS4A.
The cell pellet from a 10 L fermentor was resuspended in 600 ml of
lysis buffer containing 25 mM HEPES pH 7.5, 10% (v/v) glycerol,
0.3 M NaCl, 0.1% n-octyl-β-D-octyl glucoside, 2 mM β-mercap-
toethanol (βME), 4 mM MgCl2 and 19,000 units/L DNAse. Twenty
tablets of EDTA-free complete protease inhibitor cocktail (Boehringer
Mannheim) were added per liter of lysis buffer. The mixture was treated
for 2 min with a cell homogenizer (Omni Mixer ES) and cells were sub-
sequently disrupted by two passes through a Microfluidizer (Model 
M-110F, Microfluidics, MA) operated at 10,000 psi The lysate was clar-
ified by centrifugation at 85,000 × g for 60 min. The supernatant was
applied at 120 cm/h to a 10 ml Ni-NTA (Qiagen) column in the pres-
ence of 20 mM imidazole using a gradifrac system (Pharmacia). The
column was washed with 15–20 column volumes of the lysis buffer.
The bound scNS3–NS4A was eluted with ten column volumes of lysis
buffer supplemented with 250 mM imidazole. 
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The pooled fractions were further purified by size-exclusion chromato-
graphy using three sephacryl-100 size-exclusion columns (26 × 60 cm,
Pharmacia) in series (flow rate 0.5 ml/min). Columns were pre-equili-
brated in buffer containing 25 HEPES pH 7.5, 10% (v/v) glycerol, 0.3M
NaCl and 10 mM βME. Fractions containing greater than 95% pure
recombinant scNS3–NS4A, as judged by sodium dodecyl sulfate
(SDS–PAGE), were pooled. The pooled fractions were diluted with an
equal volume of buffer (25 mM HEPES pH 7.5, 10% (v/v) glycerol and
10 mM βME) and applied to a Q-Sepharose column equilibrated in
25 mM HEPES pH 7.5, 10% (v/v) glycerol, 0.15 M NaCl and 10 mM
βME. The flow-through containing the scNS3–NS4A was collected
and the final NaCl concentration adjusted to 1.0 M. The purified protein
was frozen and stored at –80°C. 
Crystallization
Purified scNS3–NS4A was concentrated to 0.07 mM by centrifugal fil-
tration. After centrifugation at 100,000 × g for 30 min, crystallization
experiments were conducted using a batch method with micro-
seeding. Crystals suitable for structure determination were grown from
a droplet containing 1 µl of protein mixed with 4 µl of a solution con-
taining 0.08 M sodium phosphate pH 6.4, 16% (w/v) PEG 6000,
32 mM di-potassium hydrogen phosphate, 8% (w/v) 2-methyl-2,4-pen-
tanediol (MPD), 5 mM HEPES, 0.2 M sodium chloride, 2% (v/v) glyc-
erol and 2 mM βME. The solution was also used to surround the
crystallization chamber containing the protein mixture placed on a
microbridge. Crystals of rectangular prism habit (20 × 20 × 50 µ)
appeared within 1–2 days. Prior to data collection, crystals were trans-
ferred for 2 min to an artificial mother liquor solution supplemented
with 20% (v/v) glycerol and flash frozen using either a nitrogen gas
stream or liquid propane.
Structure determination and analysis
scNS3–NS4A crystals are orthorhombic (space group P212121; cell
dimensions a = 91 Å, b = 111 Å, c = 141 Å) and contain two mol-
ecules per asymmetric unit (VM = 2.5 Å3 Dalton–1). Using one crystal
and a 1.000 Å wavelength, diffraction data were collected on a MAR
CCD detector at beamline X17 of the Advanced Photon Source
(Argonne, IL). A total of 270 frames were collected, each with 0.5°
oscillation range. Data were integrated, scaled and reduced with the
programs DENZO and SCALEPACK [50]. 
The scNS3–NS4A structure was determined by molecular replace-
ment methods as coded in X-PLOR [51] using the previously deter-
mined structures of the protease domain [22,24] (PDB code 1A1R)
and helicase domain [21] (PDB code 1HE1) as independent search
models. Searches using the helicase revealed two solutions, whereas
the protease yielded only a single solution. Rigid-body refinement
procedures applied using these solutions produced a globular
scNS3–NS4A molecule, which was used as the search model in a
second molecular replacement cycle. This yielded two distinct solu-
tions related by a noncrystallographic twofold symmetry axis nearly par-
allel to the b unit cell axis. The structure was further refined using
simulated-annealing and positional and B-factor refinement (X-PLOR
3.1), while gradually extending the resolution. Both search models
were derived from the HCV strain 1a, and the appropriate amino acid
changes to model the 1B strain were made after the refinement resolu-
tion was beyond 2.8 Å. The Rfree [52] was closely monitored through-
out the refinement. In the final model, continuous electron density is
observed for all residues of the protein with few exceptions. Data col-
lection, the final refinement and model statistics are listed in Table 1.
Graphics
Figures 1, 2a, 4a, 5 and 6a were generated with Molscript [53] and
Raster3D [54], Figure 2b with GRASP [55], and Figure 4b with
LIGPLOT [56].
Accession numbers
The atomic coordinates have been deposited in the Brookhaven
Protein Data Bank with accession code 1CU1.
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